226 related articles for article (PubMed ID: 30417460)
1. Clinicopathologic features of anaplastic myxopapillary ependymomas.
Lee JC; Sharifai N; Dahiya S; Kleinschmidt-DeMasters BK; Rosenblum MK; Reis GF; Samuel D; Siongco AM; Santi M; Storm PB; Ferris SP; Bollen AW; Pekmezci M; Solomon DA; Tihan T; Perry A
Brain Pathol; 2019 Jan; 29(1):75-84. PubMed ID: 30417460
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
Prayson RA
Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
[TBL] [Abstract][Full Text] [Related]
3. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the Literature.
Gitto L; Serinelli S; Galbraith K; Williams M; Mirchia K; Galgano MA; Krishnamurthy S; de la Roza G; Viapiano MS; Walker JM; Jour G; Serrano J; DeLorenzo M; Snuderl M; Richardson TE
J Neuropathol Exp Neurol; 2020 Oct; 79(10):1044-1053. PubMed ID: 32743660
[TBL] [Abstract][Full Text] [Related]
5. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.
Prayson RA
Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291
[TBL] [Abstract][Full Text] [Related]
6. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.
Ho DM; Hsu CY; Wong TT; Chiang H
J Neurooncol; 2001 Aug; 54(1):77-85. PubMed ID: 11763426
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Surgical Resection Outcomes of Pediatric Myxopapillary Ependymoma: Experience of Two Centers and Brief Literature Review.
Abdallah A; Emel E; Gündüz HB; Sofuoğlu ÖE; Asiltürk M; Abdallah BG
World Neurosurg; 2020 Apr; 136():e245-e261. PubMed ID: 31899399
[TBL] [Abstract][Full Text] [Related]
8. Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management.
Kraetzig T; McLaughlin L; Bilsky MH; Laufer I
J Neurosurg Spine; 2018 Feb; 28(2):201-208. PubMed ID: 29219779
[TBL] [Abstract][Full Text] [Related]
9. Myxopapillary Ependymoma with Anaplastic Features: A Case Series and Review of the Literature.
Khristov V; Shenoy G; Mau C; Mrowczynski O; Rizk E; Pu C; Specht CS; Aregawi D
World Neurosurg; 2022 Feb; 158():e735-e745. PubMed ID: 34800728
[TBL] [Abstract][Full Text] [Related]
10. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
11. Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas.
Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Myxopapillary Ependymomas: A Clinicopathologic Evaluation.
Eschbacher KL; Rao AN; Greipp PT; Gliem TJ; Daniels DJ; Warad D; Eckel LJ; Raghunathan A
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1194-e1200. PubMed ID: 33395181
[TBL] [Abstract][Full Text] [Related]
13. Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.
Swanson AA; Raghunathan A; Jenkins RB; Messing-Jünger M; Pietsch T; Clarke MJ; Kaufmann TJ; Giannini C
J Neuropathol Exp Neurol; 2019 Sep; 78(9):791-797. PubMed ID: 31373367
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic myxopapillary ependymoma: A case report and review of literature.
Kanno H; Kanetsuna Y; Shinonaga M
World J Clin Oncol; 2021 Nov; 12(11):1072-1082. PubMed ID: 34909401
[TBL] [Abstract][Full Text] [Related]
15. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
16. When a dermatopathologist encounters the ultra-rare: A case series of superficial soft tissue/cutaneous myxopapillary ependymomas.
Chatzopoulos K; Hytiroglou P; Charville GW; Toland AMS; Martinez-Lage M; Cimino PJ; Rosenblum MK; Linos K
J Cutan Pathol; 2024 Jan; 51(1):20-29. PubMed ID: 37317818
[TBL] [Abstract][Full Text] [Related]
17. Spinal ependymoma with regional metastasis at presentation.
Pencovich N; Bot G; Lidar Z; Korn A; Wostrack M; Meyer B; Bydon M; Jallo G; Constantini S
Acta Neurochir (Wien); 2014 Jun; 156(6):1215-22. PubMed ID: 24604138
[TBL] [Abstract][Full Text] [Related]
18. Myxopapillary ependymoma with anaplastic features.
Awaya H; Kaneko M; Amatya VJ; Takeshima Y; Oka S; Inai K
Pathol Int; 2003 Oct; 53(10):700-3. PubMed ID: 14516321
[TBL] [Abstract][Full Text] [Related]
19. Remarkable efficacy of temozolomide for relapsed spinal myxopapillary ependymoma with multiple recurrence and cerebrospinal dissemination: a case report and literature review.
Fujiwara Y; Manabe H; Izumi B; Shima T; Adachi N
Eur Spine J; 2018 Jul; 27(Suppl 3):421-425. PubMed ID: 29270703
[TBL] [Abstract][Full Text] [Related]
20. Surgical outcomes of spinal cord and cauda equina ependymoma: Postoperative motor status and recurrence for each WHO grade in a multicenter study.
Kobayashi K; Ando K; Kato F; Kanemura T; Sato K; Kamiya M; Nishida Y; Ishiguro N; Imagama S
J Orthop Sci; 2018 Jul; 23(4):614-621. PubMed ID: 29610008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
